Disease Overview：Oligospermia（OSA）
Oligozoospermia, or low sperm count, is a common male infertility condition defined by a semen analysis revealing fewer than 15 million sperm per milliliter. It may result from endocrine imbalances (e.g., hypogonadotropic hypogonadism), varicocele, cryptorchidism, genetic factors (e.g., Y-chromosome microdeletions, Klinefelter syndrome), infections (e.g., chronic prostatitis), environmental exposures, or idiopathic causes. Diagnosis requires standardized WHO-compliant semen analysis, hormonal profiling (FSH, LH, testosterone, prolactin), scrotal ultrasound, and, when indicated, genetic testing or testicular biopsy. Management is tailored: lifestyle optimization, pharmacotherapy (e.g., clomiphene citrate, aromatase inhibitors), surgical correction (e.g., varicocelectomy), or assisted reproductive technologies (ART) such as IUI or ICSI—particularly when sperm concentration falls below 5 million/mL or motility is severely impaired.
China offers distinct advantages for oligozoospermia treatment: leading urology-and-andrology centers—many affiliated with top-tier academic hospitals—employ advanced diagnostics including high-magnification sperm morphology assessment (MSOME), next-generation sequencing for genetic screening, and robotic-assisted microsurgical techniques. Success rates for varicocelectomy exceed 70% in restoring normozoospermia, while ICSI pregnancy rates surpass 55% per cycle in experienced centers. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising clinical standards or regulatory oversight (NMPA-approved devices, ISO-certified labs). As a dedicated medical tourism agency, we facilitate seamless international care—vetting JCI-accredited hospitals, coordinating appointments with board-certified andrologists, providing itemized, transparent pricing, and offering end-to-end support including visa assistance, translation, accommodation, and post-treatment follow-up.
Oligospermia: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown for Oligospermia (Male Infertility)
Non-Surgical / Conservative / Medication Options
*Target criteria:* Idiopathic oligospermia, mild–moderate cases (sperm count 5–15 million/mL), hormonal imbalances (e.g., low testosterone, elevated prolactin), varicocele-related subfertility without surgical indication.
- •Initial Diagnostic Workup
- Hormone panel (FSH, LH, testosterone, prolactin, estradiol): $85–$110 - Scrotal ultrasound + Doppler: $75–$95 - Genetic screening (karyotype + Y-microdeletion) *if indicated*: $220–$280
- •Pharmacotherapy (3–6 months)
- Letrozole (2.5 mg/day): $35–$50/month - hCG injections (1,000 IU twice weekly): $180–$240/month - Antioxidant combo (vitamin E, C, zinc, L-carnitine): $20–$35/month
Surgical / Procedural Options
*Eligibility:* Clinical or subclinical varicocele (Grade II/III), obstructive azoospermia with patent epididymis, failed medical therapy in moderate oligospermia with confirmed venous reflux.
- •Preoperative Workup
- Repeat semen analysis + post-vasography imaging (if obstruction suspected): $110–$140
- •Procedures
- Laparoscopic varicocelectomy: $1,200–$1,550 - Percutaneous embolization (radiology suite): $1,300–$1,700 - Testicular sperm extraction (TESE) *for severe oligospermia unresponsive to other therapy*: $1,900–$2,350
Special / Complex Condition Management
- •Hypogonadotropic hypogonadism (HH):
- hCG + FSH combination therapy (12 months): $3,800–$4,700 total
- •Post-chemotherapy oligospermia:
- •Genetic causes (e.g., CFTR mutations):
Quick Selection Guide
- •Age <35, mild oligospermia (10–15 M/mL), budget <$500: Start with 3-month clomiphene + antioxidants ($120–$220 total) + repeat semen analysis.
- •Age 35–42, moderate oligospermia (5–10 M/mL), varicocele on ultrasound: Microsurgical varicocelectomy ($1,450–$1,850) offers highest cost-adjusted efficacy.
- •Age >42, severe oligospermia (<5 M/mL), comorbid HH or prior chemo: Initiate hCG+FSH therapy ($3,800–$4,700) or proceed directly to TESE + IVF-ICSI.
- •Budget-constrained (<$800), idiopathic case: Hormone panel + antioxidant regimen ($320–$420) + lifestyle optimization (smoking cessation, weight loss, abstinence ≤3 days).
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Oligospermia Medical Vacation Packages
Curated transparent all-inclusive packages combining Oligospermia treatment with China top medical destinations:
